Clinical Trials Directory

Trials / Terminated

TerminatedNCT02034292

Safety Study of APD-791 With Aspirin and/or Clopidogrel

Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
IlDong Pharmaceutical Co Ltd · Industry
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

Evaluating safety and PK parameter of APD-791 when co-administered with aspirin and clopidogrel.

Conditions

Interventions

TypeNameDescription
DRUGClopidogrel
DRUGAspirin
DRUGAPD791
DRUGPlacebo

Timeline

Start date
2014-02-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2014-01-13
Last updated
2019-02-15

Source: ClinicalTrials.gov record NCT02034292. Inclusion in this directory is not an endorsement.

Safety Study of APD-791 With Aspirin and/or Clopidogrel (NCT02034292) · Clinical Trials Directory